FundedIQ
Biotechnology

Osanni Bio: Funding, Investors & Team (Sep 2026)

Osanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused by retinal diseases. Leveraging design-thinking in drug development, Osanni focuses on novel ocular disease treatments intended to restore vision rather than just slow disease progression

www.osanni.bio LinkedIn San Francisco, United States 11-50 employees
Biotechnology Life Science Therapeutics
Total raised
$190M
Rounds
1
Latest
Series B
Jun 2026

Osanni Bio has raised $190M across 1 funding round on record, the most recent a Series B of $190M announced in Jun 2026.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Osanni Bio Company Profile and Key Stats

Total funding raised
$190M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series B
$190M in Jun 2026
Employees
11-50
reported band
Headquarters
San Francisco, United States

Latest funding round on record: Jun 2026.

Osanni Bio Funding Rounds

Date
Round
Amount
Series B
$190M

Osanni Bio Founders and Leadership Team

Name
Role
Contact
D Michael
Founder

No contact details are on record for this team yet.

Osanni Bio Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M
4,289
$30M

Osanni Bio's latest round of $190M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Osanni Bio in Biotechnology and San Francisco

Companies Similar to Osanni Bio

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Osanni Bio Funding FAQs

What does Osanni Bio do?

Osanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused by retinal diseases. Leveraging design-thinking in drug development, Osanni focuses on novel ocular disease treatments intended to restore vision rather than just slow disease progression

How much funding has Osanni Bio raised?

Osanni Bio has raised $190M across 1 round on record. The most recent is a Series B of $190M announced in Jun 2026.

When did Osanni Bio last raise funding?

Osanni Bio's most recent funding round on record is a Series B of $190M, announced in Jun 2026.

Who founded Osanni Bio?

FundedIQ lists D Michael (Founder) at Osanni Bio.

Where is Osanni Bio headquartered?

Osanni Bio is based in San Francisco, California, United States.

How many employees does Osanni Bio have?

Osanni Bio is in the 11-50 employee band.

How does Osanni Bio's funding compare to other Biotechnology startups?

Osanni Bio's latest round of $190M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Osanni Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Osanni Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.